{"id":20172,"date":"2021-01-29T14:07:45","date_gmt":"2021-01-29T13:07:45","guid":{"rendered":"https:\/\/ellipse.prbb.org\/?p=20172"},"modified":"2021-02-09T11:25:48","modified_gmt":"2021-02-09T10:25:48","slug":"la-ivermectina-podria-reduir-la-transmissio-viral-de-la-covid-19","status":"publish","type":"post","link":"https:\/\/ellipse.prbb.org\/ca\/la-ivermectina-podria-reduir-la-transmissio-viral-de-la-covid-19\/","title":{"rendered":"La ivermectina podria reduir la transmissi\u00f3 viral de la COVID-19"},"content":{"rendered":"\n

Un assaig cl\u00ednic pilot<\/a><\/strong> liderat per l’Institut de Salut Global de Barcelona (ISGlobal)<\/a> i la Universitat de Navarra ha observat una tend\u00e8ncia a la disminuci\u00f3 de la c\u00e0rrega viral i la <\/strong>simptomatologia<\/strong> <\/a>en pacients amb COVID-19<\/a> despr\u00e9s de l’administraci\u00f3 d’ivermectina, un f\u00e0rmac antiparasitari.<\/p>\n\n\n\n

Amb aquest estudi, englobat dins del projecte SAINT<\/a>, s’ha volgut comprovar si la dosi m\u00e0xima d’ivermectina<\/strong> aprovada a Europa \u00e9s suficient per reduir la replicaci\u00f3 del SARS-CoV-2<\/a><\/strong> (com s’ha demostrat amb anterioritat amb concentracions m\u00e9s elevades). Per fer-ho, han realitzat el seguiment de 24 pacients<\/strong> diagnosticats amb COVID-19 als quals se’ls va administrar el f\u00e0rmac o un placebo en les primeres 72h despr\u00e9s de l’aparici\u00f3 de s\u00edmptomes.<\/p>\n\n\n\n

Aix\u00ed, encara que els resultats no han estat estad\u00edsticament significatius, han perm\u00e8s observar una menor c\u00e0rrega viral mitjana<\/strong> en el grup tractat (3 vegades menor als 4 dies i fins a 18 vegades menor passada una setmana), i una reducci\u00f3 en la durada d’alguns s\u00edmptomes<\/strong> com la p\u00e8rdua d’olfacte o la tos.<\/p>\n\n\n\n

<\/div>\n\n\n\n

\u201cS\u2019estan fent esfor\u00e7os notables per desenvolupar tractaments contra la COVID-19, per\u00f2 s\u2019ha posat menys atenci\u00f3 a trobar f\u00e0rmacs que redueixin la transmissi\u00f3 del virus\u201d
Carlos Chaccour<\/strong>, investigador de l’ISGlobal i coordinador de l’estudi.<\/p><\/blockquote>\n\n\n\n

<\/div>\n\n\n\n

Segons els autors i autores, amb aquest estudi pilot s’ha observat una tend\u00e8ncia encoratjadora<\/strong> que hauria de servir per continuar investigant el potencial farmacol\u00f2gic de la ivermectina<\/strong> a trav\u00e9s d’estudis de major escala i amb una mostra de pacients m\u00e9s diversa.<\/p>\n\n\n\n

<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Un estudi pilot de l’ISGlobal i la Universitat de Navarra ha volgut comprovar l’efectivitat d’aquest f\u00e0rmac antiparasitari, com a via complement\u00e0ria al desenvolupament de vacunes contra la COVID-19.<\/p>\n","protected":false},"author":9,"featured_media":20179,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[651,721,233,295],"new-type":[35],"class_list":["post-20172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recerca","tag-assaigs-clinics","tag-coronavirus-ca","tag-farmacologia","tag-isglobal-cat","new-type-noticies"],"acf":[],"_links":{"self":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/20172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/comments?post=20172"}],"version-history":[{"count":5,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/20172\/revisions"}],"predecessor-version":[{"id":20183,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/20172\/revisions\/20183"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media\/20179"}],"wp:attachment":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media?parent=20172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/categories?post=20172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/tags?post=20172"},{"taxonomy":"new-type","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/new-type?post=20172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}